Transaction enables Opocrin to become a leading global producer of active biologics including heparin and heparinoids.
Lead Product(s): Heparin Sodium
Therapeutic Area: Hematology Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Small molecule
Partner/Sponsor/Collaborator: Cerus DMCC
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition April 29, 2020